[
    [
        {
            "time": "",
            "original_text": "上半年192家公司定增：募资3000亿 朱少醒连续四个季度加仓埃斯顿 景林定增大宝股份浮亏34%",
            "features": {
                "keywords": [
                    "定增",
                    "募资",
                    "朱少醒",
                    "埃斯顿",
                    "景林",
                    "大宝股份",
                    "浮亏"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "制造业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上半年192家公司定增：募资3000亿 朱少醒连续四个季度加仓埃斯顿 景林定增大宝股份浮亏34%",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "21健讯Daily｜华大基因获33亿元国际大单；Moderna首款季节性流感疫苗获突破；万泰生物建5亿份IVD试剂生产基地",
            "features": {
                "keywords": [
                    "华大基因",
                    "Moderna",
                    "流感疫苗",
                    "万泰生物",
                    "IVD试剂"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "医疗设备"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "21健讯Daily｜华大基因获33亿元国际大单；Moderna首款季节性流感疫苗获突破；万泰生物建5亿份IVD试剂生产基地",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华大又获8.91亿巨额海外订单！此客户订单总额高达33.8亿！",
            "features": {
                "keywords": [
                    "华大",
                    "海外订单",
                    "生物医药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大又获8.91亿巨额海外订单！此客户订单总额高达33.8亿！",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 10
            }
        }
    ]
]